Gaviscon and Diabetic ketoacidosis - a phase IV clinical study of FDA data

Summary:

Diabetic ketoacidosis is reported as a side effect among people who take Gaviscon (aluminum hydroxide; magnesium trisilicate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Jardiance, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Diabetic ketoacidosis when taking Gaviscon. It is created by eHealthMe based on reports of 11,990 people who have side effects when taking Gaviscon from the FDA, and is updated regularly.

What is Gaviscon?

Gaviscon has active ingredients of aluminum hydroxide; magnesium trisilicate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 12,355 Gaviscon users. Check the latest studies of Gaviscon.

What is Diabetic ketoacidosis?

Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies) is found to be associated with 1,095 drugs and 1,757 conditions by eHealthMe. Check the latest studies of Diabetic ketoacidosis.

On Jul, 06, 2026

11,990 people reported to have side effects when taking Gaviscon.
Among them, 13 people (0.11%) have Diabetic ketoacidosis.

Could Gaviscon cause Diabetic ketoacidosis?

Among these 13 people:

How long have people been on Gaviscon when they have Diabetic ketoacidosis? *

What is the gender of people who have Diabetic ketoacidosis when taking Gaviscon? *

female: 61.54 %
male: 38.46 %

What is the age of people who have Diabetic ketoacidosis when taking Gaviscon? *

What are other drugs people take besides Gaviscon? *

What are other side effects people have besides Diabetic ketoacidosis? *

Malaise (a feeling of general discomfort or uneasiness): 3 people, 23.08%
Dehydration (dryness resulting from the removal of water): 2 people, 15.38%
Urinary Tract Infection: 2 people, 15.38%
Hyperglycemia (high blood sugar): 2 people, 15.38%
Blood Glucose Increased: 2 people, 15.38%
Diarrhea: 2 people, 15.38%
Nausea And Vomiting: 2 people, 15.38%
Weight Increased: 1 person, 7.69%
Drug Hypersensitivity: 1 person, 7.69%
Depression: 1 person, 7.69%

What are the existing conditions these people have? *

Type 2 Diabetes: 5 people, 38.46%
Pulmonary Congestion (congestion in the lungs): 1 person, 7.69%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 7.69%
Malignant Melanoma (skin cancer rises from melancytes): 1 person, 7.69%
Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 7.69%
Impaired Gastric Emptying: 1 person, 7.69%
Gastric Disorder (disease of stomach): 1 person, 7.69%
Cough: 1 person, 7.69%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Gaviscon and have Diabetic ketoacidosis?

- Check whether Diabetic ketoacidosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gaviscon:

Gaviscon (12,355 reports)

Diabetic ketoacidosis treatments and more:

Diabetic ketoacidosis (38,040 reports)

How severe was Diabetic ketoacidosis and when was it recovered:

Diabetic ketoacidosis in Gaviscon

Expand to all the drugs that have ingredients of aluminum hydroxide; magnesium trisilicate:

Diabetic ketoacidosis and drugs with ingredients of aluminum hydroxide; magnesium trisilicate (17 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gaviscon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Diabetic ketoacidosis:

Diabetic ketoacidosis (1,095 drugs)

Browse all the conditions that are associated with Diabetic ketoacidosis:

Diabetic ketoacidosis (1,757 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aluminum hydroxide; magnesium trisilicate (the active ingredients of Gaviscon) and Gaviscon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.